BOH-2C-B
| Clinical data | |
|---|---|
| Other names | BOH-2C-B-; BOHB; β-Hydroxy-4-bromo-2,5-dimethoxyphenethylamine; β-Hydroxy-2C-B; β-OH-2C-B |
| Routes of administration | Oral |
| Drug class | Serotonin 5-HT2 receptor agonist; Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Onset of action | Unknown |
| Duration of action | Unknown |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C10H14BrNO3 |
| Molar mass | 276.130 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
BOH-2C-B, or BOHB, also known as 4-bromo-2,5-dimethoxy-β-hydroxyphenethylamine or as β-hydroxy-2C-B, is a psychedelic drug of the phenethylamine, 2C, and BOx families. It is the β-hydroxy derivative of 2C-B. The drug has been encountered as a novel designer drug.